Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Two Anti-CD20 Regimens for Fibrillary Glomerulonephritis

NCT06680349 is registered in ClinicalTrials.gov with University of Turin, Italy as lead sponsor.

NCT NCT06680349
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06680349 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Two Anti-CD20 Regimens for Fibrillary Glomerulonephritis
Lead sponsor
University of Turin, Italy
Phase
Phase 4
Overall status
Completed
Start date
December 1, 2022
Completion date
January 2, 2024
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibrillary glomerulonephritis